RENEF — Cartesian Growth II Income Statement
0.000.00%
Last trade - 00:00- $107.24m
- $115.79m
- 31
- 37
- 51
- 33
Annual income statement for Cartesian Growth II, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 |
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 3.73 | 0.881 | 2.03 | 1.04 |
| Operating Profit | -3.73 | -0.881 | -2.03 | -1.04 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -3.73 | 4.93 | 11.4 | 8.21 |
| Net Income After Taxes | -3.73 | 4.93 | 11.4 | 8.21 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -3.73 | 4.93 | 11.4 | 8.21 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -3.73 | 4.93 | 11.4 | 8.21 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.149 | 0.178 | 0.413 | 0.404 |
| Dividends per Share |